| Patent application number | Description | Published |
|---|
| 20080254643 | STRUCTURE TO IMPROVE ADHESION BETWEEN TOP CVD LOW-K DIELECTRIC AND DIELECTRIC CAPPING LAYER - An interconnect structure in which the adhesion between an upper level low-k dielectric material, such as a material comprising elements of Si, C, O, and H, and an underlying diffusion capping dielectric, such as a material comprising elements of C, Si, N and H, is improved by incorporating an adhesion transition layer between the two dielectric layers. The presence of the adhesion transition layer between the upper level low-k dielectric and the diffusion barrier capping dielectric can reduce the chance of delamination of the interconnect structure during the packaging process. The adhesion transition layer provided herein includes a lower SiO | 10-16-2008 |
| 20080270081 | NON-DESTRUCTIVE, BELOW-SURFACE DEFECT RENDERING USING IMAGE INTENSITY ANALYSIS - Non-destructive, below-surface defect rendering of an IC chip using image intensity analysis is disclosed. One method includes providing an IC chip delayered to a selected layer; determining a defect location below a surface of the selected layer using a first image of the IC chip obtained using an CPIT in a first mode; generating a second image of the IC chip with the CPIT in a second mode, the second image representing charged particle signal from the defect below the surface of the selected layer; and rendering the defect by comparing an image intensity of a reference portion of the second image not including the defect with the image intensity of a defective portion of the second image including the defect, wherein the reference portion and the defective portion are of structures expected to be substantially identical. | 10-30-2008 |
| Patent application number | Description | Published |
|---|
| 20090296378 | Illuminated Product Display with Consumer Interaction and Product Synchronization - An illuminating product display providing customer interaction and product synchronization is disclosed. The product display may include an upright display member having an illuminating member and lighting niches through which dynamic light shows may be projected. A product may be positioned in a lighting niche. A product experience shelf may also be coupled to the upright display member. The product experience shelf may include translucent recesses for holding and illuminating demonstration products. The product experience shelf may also incorporate an illuminated ring or border lining the outer edge of each recess for additional lighting effects. An interactive customer interface may allow customers to adjust a control module which coordinates synchronized dynamic light shows throughout the display. The customer interface may also be illuminated and positioned on the product experience shelf. Furthermore, the dynamic light shows may be synchronized with the lighting products. | 12-03-2009 |
| 20090296385 | Method of Displaying Illuminated Products - A method of displaying and merchandising a product that that provides customer interaction and product synchronization is disclosed. The method provides a product display that may include an upright display member having an illuminating member and lighting niches through which dynamic light shows may be projected. A product may be positioned in a lighting niche. A product experience shelf may also be coupled to the upright display member. The product experience shelf may include translucent recesses for holding and illuminating products and or samples of products. The product experience shelf may also incorporate an illuminated ring or border lining the outer edge of each recess for additional lighting effects. The method also provides an interactive customer interface that allows customers to adjust a control module which coordinates synchronized dynamic light shows throughout the display. The customer interface may also be illuminated and positioned on the product experience shelf. Furthermore, the method provides synchronization of dynamic light shows with the products on display. | 12-03-2009 |
| 20100283407 | CIRCUIT FOR COLOR CHANGING LED DEVICES WITH VOLATILE ACTIVE EMISSIONS - A control circuit for color changing LED devices with volatile active emissions and hidden input jacks is disclosed. The circuit allows the device to use variously sized power adapters, and a plurality of colored LEDs positioned so as to emit a colored light show. The circuit also includes a volatile active dispenser to control volatile active emission rates. A hidden input jack is also disposed to provide additional power as required. Thus, the circuit provides the combination of illumination and/or ambient light, colored light shows, volatile active emission control, and combinations thereof, within a single standalone device. | 11-11-2010 |
| 20110006072 | Retail Fragrance Sampling Display - A fragrance sampling display for retail environments is disclosed. The sampling display may include a dock having a removable faceplate and sidewalls. The dock may include one or more receptacles and one or more scent modules, wherein each scent module is associated with and partially inserted into only one of the receptacles. The scent modules may be removably disposed in the corresponding receptacles by retractable cords. Each of the scent modules may include a different volatile active corresponding to a different fragrance product and vent holes to facilitate passive emission of the associated fragrance. The vent holes may be configured so as to be substantially sealed while the associated scent module is in its respective receptacle. | 01-13-2011 |
| 20110148329 | MULTI-SENSORY PRODUCT COMBINING REEDS, VOLATILE ACTIVES DIFFUSION, FORM-WITHIN-A-FORM CONSTRUCTION, AND LIGHT SHOW CAPABILITIES - A multi-sensory product able to disperse chemical actives using reeds or other wicks, as well as providing a light show is disclosed. The product includes a form-within-a-form design wherein the inner form or vase is able to store the chemical actives, as well as mount the reeds or other wicks. The outer vase complements the aesthetics of the inner vase while at the same time concealing the electronics of the device. The electronics of the device can include a power source, as well as a circuit board for driving LEDs mounted thereon. The LEDs can generate a light show which can be refracted and diffused through the glass or polymer material forming the inner and outer vases thereby creating an aesthetically pleasing and multi-sensory experience through the use of the product. | 06-23-2011 |
| 20120199612 | ATTACHMENT MECHANISM FOR A CONTAINER - A container has a body with a product disposed therein. A pedestal with a valving structure extends from the body. A bracket has a sidewall with at least one slot extending therein. The bracket includes a second pedestal provided interiorly of the sidewall, which is shaped to fittingly receive the pedestal of the body. The second pedestal includes at least one extending flange. Each of the at least one extending flanges extends toward the sidewall. | 08-09-2012 |
| 20120199613 | ATTACHMENT MECHANISM FOR A CONTAINER - A product dispensing system includes an overcap that has a locking element extending therefrom. A container has a product disposed therein. A bracket is attached to the container. The bracket includes at least one flange and at least one slot. The at least one flange extends toward the at least one slot. A resilient member is disposed within the locking element. | 08-09-2012 |
| Patent application number | Description | Published |
|---|
| 20090048122 | Stabilized polypeptide compositions - The invention is based, at least in part, on the development of stabilized binding molecules that consist of or comprise a stabilized scFv and methods for making such stabilized molecules. | 02-19-2009 |
| 20090092614 | Anti-IGF-1R Antibodies and Uses Thereof - The invention relates to antibodies which bind to insulin like growth factor receptor-1 (IGF-1R) and uses thereof, in particular in the diagnosis and treatment of cancer. Specific human and murine monoclonal antibodies which inhibit IGF-1R-mediated pro-survival and tumor proliferation pathways, and variants, fragments, and derivatives thereof are provided. Also provided are specific human and murine monoclonal antibodies capable of synergistically inhibiting the ability of the ligands, insulin like growth factor 1 (IGF-1) and insulin like growth factor 2 (IGF-2), to bind to IGF-1R; as well as fragments, variants and derivatives of such antibodies. Antibodies of the invention produce such synergistic effects via allosteric and/or competitive inhibition of IGF-1R ligand binding. | 04-09-2009 |
| 20090130105 | COMPOSITIONS THAT BIND MULTIPLE EPITOPES OF IGF-1R - The instant invention is based, at least in part on the finding that binding molecules which bind to different epitopes within IGF-1R result in improved IGF-1 and/or IGF-2 blocking capabilities when compared to binding molecules that bind to a single IGF-1R epitope. The instant invention provides compositions that bind to multiple epitopes of IGF-1R, for example, combinations of monospecific binding molecules or multispecific binding molecules (e.g., bispecific molecules). Methods of making the subject binding molecules and methods of using the binding molecules of the invention to antagonize IGF-1R signaling are also provided. | 05-21-2009 |
| 20090155255 | CD23 BINDING MOLECULES AND METHODS OF USE THEREOF - The invention is based, at least in part, on the development of multivalent and stabilized forms of CD23 binding molecules and methods of use thereof for the treatment of immune cell disorders, including leukemias or lymphomas such as CLL. | 06-18-2009 |
| 20110301331 | Stabilized polypeptide compositions - The invention is based, at least in part, on the development of stabilized binding molecules that consist of or comprise a stabilized scFv and methods for making such stabilized molecules. | 12-08-2011 |
| 20120100140 | STABILIZED FC POLYPEPTIDES WITH REDUCED EFFECTOR FUNCTION AND METHODS OF USE - A method of producing Fc-containing polypeptides, such as antibodies, having stabilized Fc regions is provided, together with stabilized Fc polypeptides produced according to these methods as well as methods of using such antibodies as therapeutics. | 04-26-2012 |
